ArticleCMAJ open

Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study.

Anat Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.